Editor-in-Chief |
Highlights |
- Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis
Treatment with non-anthracycline (ANT)-based chemotherapy has increased survival in patients with extranodal natural killer/T-cell lymphoma (ENKTCL). However, the relative efficacy of various drug combinations has been contentious.
Read More >> - Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL, with or without chemotherapeutic agents.
Read More >> - Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully analyzed.
Read More >> - Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment
T-lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) is a malignancy comprised of T-lymphoblasts that can present as one of four clinical subtypes (pro-T, pre-T, cortical T, and mature T).
Read More >> - Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This entity is well known to be associated with poor responses to available treatment options and dismal outcomes.
Read More >>
Featured |
|
| Featured |
|
Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis | Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia |
Key Clinical Image |
Sickle Cell Trait: Is It Always Benign? |
Current Issue |
|
Vol. 13, No. 5, Oct 2024
Table of Contents
Original Article
Ferritin and Iron Levels Inversely Associated With Lymphoma Risk: A Mendelian Randomization Study | Abstract HTML PDF |
Boyuan Wu | 179-185 |
doi: https://doi.org/10.14740/jh1335 |
Freedom From Bleeds With Low-Dose Emicizumab Prophylaxis in Inhibitor-Positive Hemophilia A | Abstract HTML PDF |
Nita Radhakrishnan, Archit Pandharipande, Savitri Singh, Shruti Verma, Eby P. Baby, Amit Pandey | 186-191 |
doi: https://doi.org/10.14740/jh1346 |
The Influence of Circulating Exosomes Derived From Younger and Older Donors on Hypoxia-Inducible Factor 1 Alpha Gene Expression and P21 Protein in Cord Blood Hematopoietic Stem Cells | Abstract HTML PDF |
Zahra Rasti, Reza Afrisham, Elahe Bahrami Vahdat, Zahra Kashanikhatib, Seyed Hadi Mousavi, Shaban Alizadeh | 192-199 |
doi: https://doi.org/10.14740/jh1291 |
Short Communication
Utility of p53 Immunohistochemical Staining for Risk Stratification of Mantle Cell Lymphoma | Abstract HTML PDF |
Ibrahim Elsharawi, Sorin Selegean, Michael Carter | 200-206 |
doi: https://doi.org/10.14740/jh1333 |
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience | Abstract HTML PDF |
Ciprian Jitaru, Argyris Symeonidis, Sorina Badelita, Eirini Katodritou, Andrei Colita, Anastasia Mpanti, Anamaria Bancos, Bogdan Tigu, Petra Rotariu, Laura Urian, Ioana Rus, Delia Dima, Anca Bojan, Marc Damian, Vasiliki Labropoulou, Mihai Stefan Muresan, Despina Fotiou, Bogdan Fetica, Bobe Petrushev, Angela Dascalescu, Dimitra Dalampira, Sanda Buruiana, Catalin Constantinescu, Mihnea Zdrenghea, Meletios A. Dimopoulos, Ciprian Tomuleasa, Evangelos Terpos | 207-215 |
doi: https://doi.org/10.14740/jh1343 |
Case Report
Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma to Histiocytic/Dendritic Cell Sarcoma | Abstract HTML PDF |
Jennifer Cai, David Fernandez-Hazoury, Gene Yoshikawa, Amani Minja, Hehua Huang, Andrew Hwang, Xin Qing | 216-223 |
doi: https://doi.org/10.14740/jh1310 |
Scedosporium Brain Abscess: A Rare and Fatal Drawback of Bruton Tyrosine Kinase Inhibitor Therapy | Abstract HTML PDF |
Matteo Dalmazzo, Melissa Padrini, Sofia Camerlo, Giorgio Rosati, Tiziano Tommaso Busana, Paolo Nicoli, Fabio Perotto, Luca Davicco, Pietro Caironi, Marco De Gobbi, Alessandro Morotti | 224-228 |
doi: https://doi.org/10.14740/jh1263 |
Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Associated With t(1;22)(p22;q11.2) Mutation | Abstract HTML PDF |
Lane Lerner, Sushanth Sreenivasan, Chelsea Peterson, Maitreyee Rai, Pragnan Kancharla, Samuel Santosa, Mark Bunker, Yazan Samhouri | 229-237 |
doi: https://doi.org/10.14740/jh1284 |
Primary Refractory Discordant Diffuse Large B-Cell and Classical Hodgkin Lymphoma | Abstract HTML PDF |
Yuxin Bai, Samantha Bolger, Sahar Khan, Nikhil Sangle, Luojun Wang, Andrea L. Cervi | 238-244 |
doi: https://doi.org/10.14740/jh1303 |
Successful Treatment of Idiopathic Multicentric Castleman Disease With Rash as the Initial Symptom Using a Rituximab-Based Regimen | Abstract HTML PDF |
Li Zhu, Yi Liu, Fang Yu, Xue Jiao Yin, Qiu Mei Yao, Hai Tao Meng, Liang Shun You, Hong Yan Tong | 245-249 |
doi: https://doi.org/10.14740/jh1313 |
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis | Abstract HTML PDF Suppl1 |
Charley Jang, Jingmei Hsu | 250-258 |
doi: https://doi.org/10.14740/jh1327 |
Letter to the Editor
Controversies in the Management of Ischemic Cerebrovascular Accidents in Patients With Non-Promyelocytic Acute Myeloid Leukemia | Abstract HTML PDF |
Rodrick Babakhanlou, Ravinathan Krishnadasan | 259-260 |
doi: https://doi.org/10.14740/jh1342 |